Lymphoma and Disability Benefits

Lymphoma disability claims need more detail than the word “cancer.” Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, indolent lymphoma and mantle cell lymphoma have different SSA listing provisions. Pathology, treatment history and response are central to identifying the applicable rule.

Adult SSDI and disability-based SSI generally require inability to perform substantial gainful work because of an impairment lasting or expected to last at least 12 continuous months, or expected to result in death. SSDI has work-insurance requirements; SSI has financial and other requirements. A medically qualifying cancer does not remove those program rules.

Start With the Exact Diagnosis

NCI describes lymphoma as cancer involving the lymph system. Some non-Hodgkin lymphomas grow slowly, while others are aggressive. Symptoms can include enlarged lymph nodes, fever, night sweats, weight loss and fatigue, but these symptoms do not diagnose the subtype.

Collect the pathology report, biopsy or operative note, imaging and oncology assessment. The record should identify the subtype and extent of disease. If the original reports cannot be obtained, tell SSA where treatment occurred; its cancer rules allow other sufficiently detailed medical reports in appropriate circumstances.

How Listing 13.05 Applies

The listing has separate alternatives. Aggressive non-Hodgkin lymphoma must be persistent or recurrent after initial anticancer therapy. The indolent-lymphoma provision addresses more than one anticancer treatment regimen started within 12 consecutive months; SSA’s explanatory rule excludes a change made solely by preference rather than failure to achieve disease stability.

For Hodgkin lymphoma, the listing addresses failure to achieve clinically complete remission, or recurrence within 12 months after initial anticancer therapy ends. SSA treats recurrence after that interval as a new disease for this provision. Another alternative covers mantle cell lymphoma. T-cell lymphoblastic lymphoma is evaluated under the leukemia listing, not simply grouped with every other lymphoma.

Bone marrow or stem cell transplantation is a separate alternative: SSA considers disability until at least 12 months after transplantation, then evaluates residual impairments. A plan for a transplant is not proof that transplantation has occurred. These are entry points to the full rules, not substitutes for the required medical documentation.

Treatment and Its Continuing Effects

Depending on subtype and circumstances, care can include chemotherapy, radiation, targeted therapy, immunotherapy or stem cell transplantation. Selected indolent cases may be monitored before treatment is needed. The oncology team determines the appropriate approach; observation is not the same as ignoring prescribed care.

Keep the planned regimen and the actual dates it was given. Explain whether a change reflected disease progression, adverse effects or another reason. SSA needs that context to interpret a treatment timeline. Report symptoms and side effects to the care team rather than altering treatment for a benefits application.

NCI also describes late effects that can persist after lymphoma treatment, including fatigue and certain heart, lung or nerve problems depending on the treatment. A successful cancer response does not erase a documented residual impairment. Neither does the possibility of a late effect establish that it actually occurred.

Work Capacity Beyond the Listing

If the cancer does not meet a listing, SSA considers medical equivalence and other affected body systems. It may then assess residual functional capacity and whether past or other work remains possible. Document the actual effects of treatment cycles, persistent symptoms and other conditions together.

• Identify infusion days, hospital care and medically supported recovery periods.
• Explain fatigue with examples of walking, lifting or sustained desk work, including rest breaks.
• Describe documented concentration or nerve problems and the tasks they interrupt.
• Ask the clinician to explain work restrictions, expected duration and the findings supporting them.

Explain unaffordable care, unavailable appointments or other barriers when they affected treatment. SSA’s prescribed-treatment rule applies only when its prerequisites are met and requires consideration of good cause. An unexplained missing record and a documented access problem are different evidence issues.

Common Questions

Does Starting a Second Medicine Automatically Meet the Listing?

No. A medicine within a regimen is not necessarily a new regimen. The indolent-lymphoma rule also requires the specified timing and treatment-failure context.

Can I Use a Cancer Approval Rate to Predict My Claim?

No reliable personal prediction follows from the share of awards attributed to cancer. Review the approval-data guide for the distinction between historical statistics and individual eligibility.

Next Steps and Sources

Use the application guide and medical and work records checklist. If you have a decision, read its reasons and deadlines alongside the appeals guide.

Related reading: leukemia, lung cancer. Browse the condition directory.

Official Sources

• 13.00 Cancer – Adult^[1]
• Non-Hodgkin Lymphoma Treatment – NCI
• Hodgkin Lymphoma Treatment – NCI
• Side Effects of Cancer Treatment – NCI
• Part I – General Information^[2]
• How Does Someone Become Eligible?^[3]
• Code of Federal Regulations § 404.1545^[4]
• Part II – Evidentiary Requirements^[5]
• SSR 18-3p^[6]

General educational information, not individualized medical or legal advice. Disability Benefit Guide USA is not affiliated with the Social Security Administration. Read how our guides are prepared.

Official Sources and References

These SSA.gov links support the explanations above. Official applications, account services, and agency forms are completed through SSA.

1. 13.00 Cancer – Adult — SSA.gov
2. Part I – General Information — SSA.gov
3. How Does Someone Become Eligible? — SSA.gov
4. Code of Federal Regulations § 404.1545 — SSA.gov
5. Part II – Evidentiary Requirements — SSA.gov
6. SSR 18-3p — SSA.gov